Zygmont Chester Stanley III

Zygmont Chester Stanley III is listed in filings as Chief Financial Officer at Revelation Biosciences, Inc.. This profile follows SEC Form 4 activity through May 1, 2026, including 5 public disclosures. Recent filings connect the profile to Revelation Biosciences, Inc. (REVBW). The current snapshot covers public activity from Feb 13, 2025 to May 1, 2026. Reported amounts are shown as $14.6K to $70.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.